ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

LNDZF Evome Medical Technologies Inc (CE)

0.000001
0.00 (0.00%)
07 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Evome Medical Technologies Inc (CE) USOTC:LNDZF OTCMarkets Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.000001 0.000001 0.000001 0.00 01:00:00

Form 8-K - Current report

16/08/2023 10:00pm

Edgar (US Regulatory)



false 2023-08-11 0001617765 00-0000000 Salona Global Medical Device Corp. 0001617765 2023-08-11 2023-08-11

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
___________________________

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): August 11, 2023

SALONA GLOBAL MEDICAL DEVICE CORP.
(Exact name of registrant as specified in its charter)

British Columbia 333-255642 Not Applicable
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No.)

49 Natcon Dr
Shirley, New York, United States 11967
(Address of principal executive offices) (ZIP Code)

Registrant’s telephone number, including area code: (800) 760-6826

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act: None

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b -2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.


Item 5.07. Submission of Matters to a Vote of Security Holders.

At the Annual General and Special Meeting of Stockholders of Salona Global Medical Device Corporation. (the "Company") held on August 11, 2023, at 100 SE 2nd Street, 29th Floor, Miami, FL, the following matters were submitted to a vote of stockholders and the voting results were as follows:

1. Election of Directors: The five nominees named in the Company's 2023 management information circular were elected to serve until their successors are duly elected and qualified or the next annual general meeting, based upon the following votes:

Director Nominee   Votes For     Votes Against     Votes Withheld     Broker Non-Votes
Leslie Cross   9,043,408     0     3,300,470     7,496,178
Lana Newishy   9,027,933     0     3,315,945     7,496,178
Dr. Ken Kashkin   9,035,133     0     3,308,745     7,496,178
Kyle Wilks   9,035,208     0     3,308,670     7,496,178
Michael Seckler   9,033,292     0     3,310,586     7,496,178

2. Ratification of Appointment of Independent Registered Accounting Firm. The appointment of SRCO Professional Corporation to serve as the Company's independent registered accounting firm until the next annual meeting of the Company was ratified as follows:

Votes For Votes Against Votes
Withheld
Broker Non-
Votes
16,519,313 0 3,320,743 0

3. Approval of 2023 Equity Incentive Plan. The 2023 Equity Incentive Plan of the Company was approved based upon the following votes:

Votes For Votes Against Votes
Withheld
Broker Non-
Votes
8,916,870 3,427,008 0 7,496,178


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused Current Report on Form 8-K to be signed on its behalf by the undersigned hereunto duly authorized.

  SALONA GLOBAL MEDICAL DEVICE CORPORATION
   
   
Date:  August 15, 2023 By:  /s/ Dennis Nelson                                
  Name: Dennis Nelson
  Title: Chief Financial Officer


v3.23.2
Document and Entity Information Document
Aug. 11, 2023
Document Information [Line Items]  
Document Type 8-K
Document Creation Date Aug. 11, 2023
Document Period End Date Aug. 11, 2023
Amendment Flag false
Entity Registrant Name Salona Global Medical Device Corp.
Entity Address, Address Line One 49 Natcon Dr
Entity Address, City or Town Shirley
Entity Address, State or Province NY
Entity Address, Country US
Entity Address, Postal Zip Code 11967
Entity Incorporation, State Country Name A1
City Area Code 800
Local Phone Number 760-6826
Entity File Number 333-255642
Entity Central Index Key 0001617765
Entity Emerging Growth Company true
Entity Tax Identification Number 00-0000000
Entity Ex Transition Period false
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false

1 Year Evome Medical Technologies (CE) Chart

1 Year Evome Medical Technologies (CE) Chart

1 Month Evome Medical Technologies (CE) Chart

1 Month Evome Medical Technologies (CE) Chart